Superworth

Natera price to free cash flow NTRA

Market value divided by free cash flow over the last twelve months, since 2025.

Today, Nov 3, 2026
n/m
a sliver of free cash flow
Last meaningful
367×
Jul 2026
Peer median
38.4×

Natera's price to free cash flow is not a meaningful number today: a multiple this high rests on a sliver of free cash flow.

It was last meaningful in Jul 2026, at 367×.

Price to free cash flow over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far367×237×383×
2025304×199×318×

Against its peers

Companies in Medical - Diagnostics & Research nearest Natera's size, closest first, today.

CompanyPrice to free cash flow
NTRANateran/m
IDXXIDEXX Laboratories41.5×
AAgilent Technologies39.1×
WATWaters117×
IQVIQVIA19.4×
ILMNIllumina38.4×
MTDMettler-Toledo International39.6×
LHLabcorp25.0×
DGXQuest Diagnostics20.0×
DHRDanahern/m
MEDPMedpace25.6×
Peer median38.4×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Natera

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.